CPHI to Hold Second Quarter 2020 Earnings Conference Call On Friday August 14, 2020 at 8:30 a.m. ET

Rhea-AI Summary

China Pharmaceutical Holdings Limited (NYSE American: CPHI) will hold its Q2 2020 earnings conference call on August 14, 2020, at 8:30 a.m. ET. Participants must register in advance to receive dial-in details. The call will provide insights into the company's financial performance and strategic direction. A replay will be available until August 22, 2020. China Pharma focuses on specialty pharmaceuticals in China, targeting high-incidence conditions such as cardiovascular and infectious diseases, supported by a nationwide distribution network.

Positive

• Company prepares to share Q2 2020 financial performance and strategy insights during upcoming earnings call.
• China Pharma's focus on high-demand therapeutic areas may lead to growth opportunities.

Negative

• None.

HAIKOU CITY, China, Aug. 11, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans to hold its 2^nd quarter 2020 earnings conference call on Friday, August 14, 2020 at 8:30 a.m. ET.

Joining the Conference Call: 
1. Please register in advance of the conference using the link provided below. Upon registering, you will be provided with participant dial-in numbers, Direct Event passcode and unique registrant ID.
2. In the 10 minutes prior to the call start time, you will need to use the conference access information provided in the email received at the point of registering.

Direct Event online registration:
http://apac.directeventreg.com/registration/event/7427437

A replay of the call will be accessible through August 22, 2020 by dialing 1-855-452-5696 or 61-281-990-299 for international callers, Conference ID # 7427437.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products, focusing on conditions with high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnique Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit www.chinapharmaholdings.com. The Company routinely posts important information on its website.

Company contact:
Ms. Diana Na Huang     
BOD Secretary & IR Manager
China Pharma Holdings, Inc.                           
Phone: +86-898-6681-1730 (China)                                       
Email: hps@chinapharmaholdings.com      

View original content:http://www.prnewswire.com/news-releases/cphi-to-hold-second-quarter-2020-earnings-conference-call-on-friday-august-14-2020-at-830-am-et-301110084.html

SOURCE China Pharma Holdings, Inc.

FAQ

When will China Pharmaceutical Holdings hold its Q2 2020 earnings call?

The earnings conference call for Q2 2020 will take place on August 14, 2020, at 8:30 a.m. ET.

How can I register for the China Pharmaceutical Holdings earnings call?

Registration for the earnings call can be completed online at the provided link in the press release.

What topics will be covered in China Pharmaceutical Holdings' earnings call?

The call will cover Q2 2020 financial performance and strategic insights of the company.

Is there a replay available for the earnings call?

Yes, a replay of the earnings call will be available until August 22, 2020.